Fundz

Korsana Biosciences Appoints Matthew Leoni as Chief Medical Officer and Gan Wei as Chief Technical Officer

PUBLIC · KRSAAug 03, 2026

Position

Chief Medical Officer

Company

Korsana Biosciences

Matthew Leoni, M.D.
WalthamBiotechnologyHealthcareHealth CareTherapeutics

Description

Korsana Biosciences, Inc. has announced the appointment of Matthew Leoni, M.D., as Chief Medical Officer and Gan Wei, Ph.D., as Chief Technical Officer. These appointments are part of the company's strategy to strengthen its leadership as it enters the next phase of growth.

Who to call at Korsana Biosciences, and when

A new leader at Korsana Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Korsana Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Korsana Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Korsana Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Korsana Biosciences

Location

Waltham, Massachusetts, United States

About

Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary THETA™ therapeutic targeting platform to improve drug delivery and efficacy. Founded in 2024, Korsana aims to elevate patient care by creating potentially best-in-class therapeutics. The company's lead program, KRSA-028, targets amyloid beta and demonstrates strong preclinical data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Korsana Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Peter
Likely contact at this company
••••••••@••••••••

See Peter's verified email →

Anjeza
Likely contact at this company
••••••••@••••••••

See Anjeza's verified email →

Juan
Senior decision-maker at this company
••••••••@••••••••

See Juan's verified email →

Kyle
Senior decision-maker at this company
••••••••@••••••••

See Kyle's verified email →

Jason
Senior decision-maker at this company
••••••••@••••••••

See Jason's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Korsana Biosciences's next move

Learn about Strategic plan

Korsana Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.